6 unknown, 3 completed, 2 recruiting, 1 withdrawn. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Unknown 6, Completed 3, Recruiting 2, Withdrawn 1 |
Follow Cholangiocarcinoma: new trials by email Literature Review of Cholangiocarcinoma trials Research Report on Cholangiocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies Olutasidenib, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and OATP1B1 Probe Substrates - AML (Acute Myeloid Leukemia), Glioma | Phase 4 | Recruiting | Rigel Pharmaceuticals | 16 | 2026-02-23 | 2026-08-11 |
| Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma Lenvatinib - Intrahepatic Cholangiocarcinoma | Phase 4 | Unknown | Zhiyong Huang | 20 | 2024-05-30 | 2024-05-22 |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy Photosensitizer, Radiofrequency ablation (RFA) - Hilar Cholangiocarcinoma | Phase 4 | Recruiting | University of Leipzig | 258 | 2023-02-10 | 2025-03-27 |
| Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma Recombinant Human Adenovirus Type 5, HAIC of FOLFOX - Cholangiocarcinoma, Intrahepatic | Phase 4 | Unknown | Beijing Tsinghua Chang Gung Hospital | 66 | 2022-08-01 | 2024-03-04 |
| Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy Enteral nutrition, Oral nutrition - Pancreatic Cancer, Cancer of the Duodenum | Phase 4 | Unknown | Medical University of Warsaw | 96 | 2016-11-01 | 2016-11-23 |
| Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery Sevoflurane, Desflurane - Hepatocellular Carcinoma, Hepatoma | Phase 4 | Withdrawn | Tokyo Medical and Dental University | 2014-07-01 | 2023-05-03 | |
| Etomidate vs. Midazolam for Sedation During ERCP Etomidate, Midazolam, Meperidine - Choledocholithiasis, Cholangiocarcinoma | Phase 4 | Completed | Cheju Halla General Hospital | 63 | 2013-04-01 | 2015-06-29 |
| Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture SEMS insertion, DLS insertion - Bile Duct Obstruction, Klatskin's Tumor | Phase 4 | Unknown | Soon Chun Hyang University | 100 | 2010-05-01 | 2011-03-10 |
| Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma Preoperative biliary drainage - Cholangiocarcinoma, Drainage | Phase 4 | Unknown | Sun Yat-sen University | 82 | 2008-05-01 | 2008-11-25 |
| Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent biliary stent - Unresectable Hilar Cholangiocarcinoma | Phase 4 | Unknown | Khon Kaen University | 80 | 2008-01-01 | 2008-09-04 |
| Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma biliary stent (self expandable metallic stent), PS - Hilar Cholangiocarcinoma | Phase 4 | Completed | Khon Kaen University | 108 | 2007-11-01 | 2011-12-23 |
| Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors oral nutritional supplement rich in eicosapentanoic acid - Colorectal Neoplasms, Hepatocellular Carcinoma | Phase 4 | Completed | Charite University, Berlin, Germany | 30 | 2005-01-01 | 2008-05-09 |
Klatskin Tumor (4) · Carcinoma, Hepatocellular (2) · Pancreatic Neoplasms (2) · Bile Duct Neoplasms (1) · Choledocholithiasis (1) · Cholestasis (1) · Colorectal Neoplasms (1) · Duodenal Neoplasms (1) · Gallbladder Neoplasms (1) · Glioma (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1) · Pancreatitis (1) · Pancreatitis, Chronic (1)
Adenocarcinoma (12) · Carcinoma (12) · Neoplasms by Histologic Type (12) · Neoplasms, Glandular and Epithelial (12) · Neoplasms (11) · Digestive System Diseases (6) · Digestive System Neoplasms (5) · Neoplasms by Site (5) · Biliary Tract Diseases (4) · Bile Duct Diseases (3) · Biliary Tract Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2)
Self Expandable Metallic Stents (2) · Cytochrome P-450 CYP1A2 (1) · Cytochrome P-450 CYP2B6 (1) · Cytochrome P-450 CYP2C19 (1) · Cytochrome P-450 CYP2C8 (1) · Cytochrome P-450 CYP2C9 (1) · Cytochrome P-450 CYP3A (1) · Desflurane (1) · Diet (1) · Eicosapentaenoic Acid (1) · Enteral Nutrition (1) · Etomidate (1) · Folfox protocol (1) · Meperidine (1) · Midazolam (1)
Khon Kaen University (2) · Beijing Tsinghua Chang Gung Hospital (1) · Charite University, Berlin, Germany (1) · Cheju Halla General Hospital (1) · Medical University of Warsaw (1) · Rigel Pharmaceuticals (1) · Soon Chun Hyang University (1) · Sun Yat-sen University (1) · Tokyo Medical and Dental University (1) · University of Leipzig (1) · Zhiyong Huang (1)
China (3) · Germany (2) · South Korea (2) · Thailand (2) · Japan (1) · Poland (1) · United States (1)
Albrecht Hoffmeister, Prof.Dr.med. (1) · Koshi Makita, M.D. (1) · Lijian Liang (1) · Marek Wronski, MD (1) · Matthias Pirlich, MD (1) · Worrarat Kongkasame, MD (1) · Xiaoyu Yin, MD (1) · Zhiyong Huang (1)